Acuvax to move to Adelaide; Opko licenses universal flu vax tech;

Vaccine Market

Australia's Acuvax is moving its headquarters to Adelaide and plans to expand with about 20 new hires. Report

Vaccine Research

Miami-based Opko Health has licensed a new universal flu vaccine technology developed by Taiwanese scientists. Report

The first African made HIV vaccine started human trials in South Africa. "If we don't find a prevention strategy for South Africa we are in big trouble. We are not going to treat ourselves out of this epidemic," researcher Linda-Gail Bekker told the AFP. "We can't afford to let six million people die." Report

Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human . primates for use in a potential transmission-blocking vaccine. Release

Novavax announced the selection of a Respiratory Syncytial Virus vaccine candidate that will be advanced into new preclinical studies to support an Investigational New Drug application. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.